NYSE - Delayed Quote • USD
Teladoc Health, Inc. (TDOC)
At close: 4:00 PM EDT
After hours: 5:33 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 22 | 19 |
| Avg. Estimate | -0.46 | -0.3 | -1.04 | -0.69 |
| Low Estimate | -0.54 | -0.41 | -1.38 | -1.17 |
| High Estimate | -0.28 | -0.17 | -0.73 | -0.16 |
| Year Ago EPS | -0.42 | -0.4 | -1.34 | -1.04 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 25 | 25 | 26 | 25 |
| Avg. Estimate | 637.29M | 662.56M | 2.66B | 2.76B |
| Low Estimate | 633.9M | 642.6M | 2.64B | 2.72B |
| High Estimate | 644.12M | 678.31M | 2.69B | 2.79B |
| Year Ago Sales | 618.31M | 649.19M | 2.6B | 2.66B |
| Sales Growth (year/est) | 3.10% | 2.10% | 2.40% | 3.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.41 | -0.37 | -0.21 |
| EPS Actual | -0.42 | -0.4 | -0.35 | -0.17 |
| Difference | 0.08 | 0.01 | 0.02 | 0.04 |
| Surprise % | 16.00% | 2.40% | 5.40% | 19.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.46 | -0.3 | -1.04 | -0.69 |
| 7 Days Ago | -0.46 | -0.3 | -1.03 | -0.71 |
| 30 Days Ago | -0.46 | -0.3 | -1.03 | -0.7 |
| 60 Days Ago | -0.43 | -0.36 | -1.23 | -0.95 |
| 90 Days Ago | -0.43 | -0.35 | -1.23 | -0.97 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | -- |
Growth Estimates
| CURRENCY IN USD | TDOC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -9.50% | -- | -- | 1.60% |
| Next Qtr. | 25.00% | -- | -- | 10.50% |
| Current Year | 22.40% | -- | -- | 5.20% |
| Next Year | 33.70% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -29.03% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Needham: Hold | 4/5/2024 |
| Maintains | Truist Securities: Hold to Hold | 3/6/2024 |
| Initiated | Cantor Fitzgerald: Overweight | 2/29/2024 |
| Initiated | Leerink Partners: Market Perform | 2/26/2024 |
| Maintains | DA Davidson: Neutral to Neutral | 2/21/2024 |
| Maintains | Citigroup: Neutral to Neutral | 2/21/2024 |
Related Tickers
AMWL American Well Corporation
0.5466
+5.54%
TXG 10x Genomics, Inc.
27.94
-3.49%
SDGR Schrödinger, Inc.
24.29
-0.21%
DOCS Doximity, Inc.
24.63
-0.77%
VEEV Veeva Systems Inc.
198.38
-0.58%
GDRX GoodRx Holdings, Inc.
6.69
-0.59%
GEHC GE HealthCare Technologies Inc.
84.49
-0.56%
SOLV Solventum Corporation
62.20
-2.86%
MNDR Mobile-health Network Solutions
27.27
+33.87%
TALK Talkspace, Inc.
3.1400
+5.72%